Catalyst Pharma Inc - CPRX - stock price prediction, stock price target, analyst ratings from 7 analysts

Catalyst Pharma Inc has a share price target of US$ 34, revenue growth forecast of 7.1%, and profit growth estimate of 7.9% for FY26, based on top 7 analyst calls.